Thyroid hormones improve cardiac function and decrease expression of pro-apoptotic proteins in the heart of rats 14 days after infarction

Apoptosis. 2016 Feb;21(2):184-94. doi: 10.1007/s10495-015-1204-3.

Abstract

Apoptosis is a key process associated with pathological cardiac remodelling in early-phase post-myocardial infarction. In this context, several studies have demonstrated an anti-apoptotic effect of thyroid hormones (TH). The aim of this study was to evaluate the effects of TH on the expression of proteins associated with the apoptotic process 14 days after infarction. Male Wistar rats (300-350 g) (n = 8/group) were divided into four groups: Sham-operated (SHAM), infarcted (AMI), sham-operated + TH (SHAMT) and infarcted + TH (AMIT). For 12 days, the animals received T3 and T4 [2 and 8 µg/(100 g day)] by gavage. After this, the rats were submitted to haemodynamic and echocardiographic analysis, and then were sacrificed and the heart tissue was collected for molecular analysis. Statistical analyses included two-way ANOVA with Student-Newman-Keuls post test. Ethics Committee number: 23262. TH administration prevented the loss of ventricular wall thickness and improved cardiac function in the infarcted rats 14 days after the injury. AMI rats presented an increase in the pro-apoptotic proteins p53 and JNK. The hormonal treatment prevented this increase in AMIT rats. In addition, TH administration decreased the Bax:Bcl-2 ratio in the infarcted rats. TH administration improved cardiac functional parameters, and decreased the expression of pro-apoptotic proteins 14 days after myocardial infarction.

Keywords: Reactive oxygen species; Redox balance; T3; T4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins / genetics
  • Apoptosis Regulatory Proteins / metabolism*
  • Cardiotonic Agents / administration & dosage*
  • Cardiotonic Agents / pharmacokinetics
  • Drug Evaluation, Preclinical
  • Gene Expression
  • Lipid Peroxidation
  • Male
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / metabolism
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Oxidation-Reduction
  • Oxidative Stress
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism
  • Thyroxine / administration & dosage*
  • Thyroxine / pharmacokinetics
  • Triiodothyronine / administration & dosage*
  • Triiodothyronine / pharmacokinetics
  • Ventricular Pressure / drug effects

Substances

  • Apoptosis Regulatory Proteins
  • Cardiotonic Agents
  • Reactive Oxygen Species
  • Triiodothyronine
  • Thyroxine